|
Volumn 8, Issue 11, 2005, Pages 909-913
|
The future of G protein-coupled receptors as targets in drug discovery
a
BioXtal
(Switzerland)
|
Author keywords
Drug discovery; Functional studies; G protein coupled receptor; Structure based drug design
|
Indexed keywords
1,1' [1,4 PHENYLENEBIS(METHYLENE)]BIS(1,4,8,11 TETRAAZACYCLOTETRADECANE);
CANDESARTAN;
CETIRIZINE;
CHEMOKINE RECEPTOR ANTAGONIST;
CLOPIDOGREL;
DESLORATADINE;
FENTANYL;
FEXOFENADINE;
G PROTEIN COUPLED RECEPTOR;
GOSERELIN;
IRBESARTAN;
LEUPRORELIN;
LIGAND;
LOSARTAN;
METOPROLOL;
MONTELUKAST;
OCTREOTIDE;
OLANZAPINE;
QUETIAPINE;
RISPERIDONE;
SALMETEROL;
SUMATRIPTAN;
TAMSULOSIN;
VALSARTAN;
ACROMEGALY;
ANTIVIRAL ACTIVITY;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CRYSTALLOGRAPHY;
DIMERIZATION;
DRUG BIOAVAILABILITY;
DRUG DESIGN;
DRUG INDICATION;
DRUG SCREENING;
DRUG STRUCTURE;
DRUG TARGETING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
HYPERTENSION;
MIGRAINE;
NONHUMAN;
PAIN;
PROSTATE CANCER;
PROSTATE HYPERTROPHY;
PROTEIN EXPRESSION;
PROTEIN FUNCTION;
PROTEIN INTERACTION;
PROTEIN PURIFICATION;
PROTEIN STRUCTURE;
RHINITIS;
SCHIZOPHRENIA;
SIGNAL TRANSDUCTION;
THROMBOSIS;
ANIMALS;
DRUG DESIGN;
DRUG EVALUATION, PRECLINICAL;
HUMANS;
RECEPTORS, G-PROTEIN-COUPLED;
SIGNAL TRANSDUCTION;
STRUCTURE-ACTIVITY RELATIONSHIP;
|
EID: 28044444551
PISSN: 13697056
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (28)
|
References (8)
|